Patents by Inventor Lars Bolund

Lars Bolund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pig model for diabetes
    Patent number: 10729112
    Abstract: The present invention relates to a transgenic pig comprising a mutated IAPP gene and displaying a phenotype associated with diabetes. The invention also relates to a transgenic blastocyst, embryo, fetus, donor cell and/or cell nucleus derived from said transgenic pig. The invention further relates to use of the transgenic pig as a model system for studying therapy, treatment and/or prevention of diabetes.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: August 4, 2020
    Assignee: Aarhus Universitet
    Inventors: Lars Bolund, Yonglun Luo
  • Pig Model for Diabetes
    Publication number: 20170231204
    Abstract: The present invention relates to a transgenic pig comprising a mutated IAPP gene and displaying a phenotype associated with diabetes. The invention also relates to a transgenic blastocyst, embryo, fetus, donor cell and/or cell nucleusderived from said transgenic pig. The invention further relates to use of the transgenic pig as a model system for studying therapy, treatment and/or prevention of diabetes.
    Type: Application
    Filed: August 28, 2015
    Publication date: August 17, 2017
    Inventors: Lars BOLUND, Yonglun LUO
  • Method for treating hyperproliferative skin diseases
    Patent number: 5164394
    Abstract: It has been discovered that 6-(substituted amino)purine cytokinins, such as kinetin, induce differentiation, and consequently reduce or eliminate the abnormally high rate of proliferation, of hyperproliferating cells associated with hyperproliferative skin diseases. Thus, the present invention provides methods and compositions for treating hyperproliferative skin diseases in mammals, particularly such diseases associated with hyperproliferating epidermal cells in humans, by administering to the hyperproliferating cells associated with such a disease, in the skin of a mammal suffering therefrom, a differentiation-inducing effective amount of a 6-(substituted amino)purine cytokinin.
    Type: Grant
    Filed: April 3, 1991
    Date of Patent: November 17, 1992
    Assignee: Senetek, PLC
    Inventors: Lars Bolund, Peter K. A. Jensen, Peter Bjerring
  • Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
    Patent number: 5021422
    Abstract: It has been discovered that 6-(substituted amino)purine cytokinins, such as kinetin, induce differentiation, and consequently reduce or eliminate the abnormally high rate of proliferation, of hyperproliferating cells associated with hyperproliferative skin diseases, such as psoriasis. Thus, the present invention provides methods and compositions for treating hyperproliferative skin diseases in mammals, particularly such diseases associated with hyperproliferating epidermal cells in humans, by administering to the hyperproliferating cells associated with such a disease, in the skin of a mammal suffering therefrom, a differentiation-inducing effective amount of a 6-(substituted amino)purine cytokinin.
    Type: Grant
    Filed: June 8, 1989
    Date of Patent: June 4, 1991
    Assignee: Senetek PLC
    Inventors: Lars Bolund, Peter K. A. Jensen, Peter Bjerring